Topology of Class A G Protein-Coupled Receptors: Insights Gained from Crystal Structures of Rhodopsins, Adrenergic and Adenosine Receptors
暂无分享,去创建一个
[1] Anat Levit,et al. Homology modeling of G-protein-coupled receptors with X-ray structures on the rise. , 2010, Current opinion in drug discovery & development.
[2] Y. Sugiyama,et al. Short-Chain Ubiquitination Is Associated with the Degradation Rate of a Cell-Surface-Resident Bile Salt Export Pump (BSEP/ABCB11) , 2009, Molecular Pharmacology.
[3] J. Dilger,et al. Site Selectivity of Competitive Antagonists for the Mouse Adult Muscle Nicotinic Acetylcholine Receptor , 2009, Molecular Pharmacology.
[4] B. Knollmann,et al. Amitriptyline Activates Cardiac Ryanodine Channels and Causes Spontaneous Sarcoplasmic Reticulum Calcium Release , 2009, Molecular Pharmacology.
[5] Fei Ye,et al. Copper Regulation of Hypoxia-Inducible Factor-1 Activity , 2009, Molecular Pharmacology.
[6] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[7] Adriaan P. IJzerman,et al. The 2.6 A Crystal Structure of a Human A2A Adenosine Receptor bound to ZM241385. , 2008 .
[8] Oliver P. Ernst,et al. Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.
[9] R. Stenkamp. Alternative models for two crystal structures of bovine rhodopsin , 2008, Acta crystallographica. Section D, Biological crystallography.
[10] Patrick Scheerer,et al. Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.
[11] Gebhard F. X. Schertler,et al. Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.
[12] Vadim Cherezov,et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.
[13] Tsutomu Kouyama,et al. Crystal structure of squid rhodopsin , 2008, Nature.
[14] Krzysztof Palczewski,et al. Vertebrate Membrane Proteins: Structure, Function, and Insights from Biophysical Approaches , 2008, Pharmacological Reviews.
[15] K. Palczewski,et al. Activation of G protein-coupled receptors: beyond two-state models and tertiary conformational changes. , 2008, Annual review of pharmacology and toxicology.
[16] H Gobind Khorana,et al. Opsin stability and folding: modulation by phospholipid bicelles. , 2007, Journal of molecular biology.
[17] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[18] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[19] Manfred Burghammer,et al. Crystal structure of a thermally stable rhodopsin mutant. , 2007, Journal of molecular biology.
[20] John R. James,et al. Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization - James and Davis reply , 2007 .
[21] A. Salahpour,et al. Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization , 2007, Nature Methods.
[22] Thomas Huber,et al. G protein-coupled receptors self-assemble in dynamics simulations of model bilayers. , 2007, Journal of the American Chemical Society.
[23] Tetsuji Okada,et al. Photoisomerization mechanism of rhodopsin and 9-cis-rhodopsin revealed by x-ray crystallography. , 2007, Biophysical journal.
[24] W. Baumeister,et al. Three-dimensional architecture of murine rod outer segments determined by cryoelectron tomography , 2007, The Journal of cell biology.
[25] Leonardo Pardo,et al. Structural models of class a G protein-coupled receptors as a tool for drug design: insights on transmembrane bundle plasticity. , 2007, Current topics in medicinal chemistry.
[26] Krzysztof Palczewski,et al. Visual Rhodopsin Sees the Light: Structure and Mechanism of G Protein Signaling* , 2007, Journal of Biological Chemistry.
[27] T. Okada,et al. X‐Ray Crystallographic Analysis of 9‐cis‐Rhodopsin, a Model Analogue Visual Pigment † , 2007, Photochemistry and photobiology.
[28] K. Palczewski,et al. Diseases caused by defects in the visual cycle: retinoids as potential therapeutic agents. , 2007, Annual review of pharmacology and toxicology.
[29] Liang Li,et al. Nanoliter microfluidic hybrid method for simultaneous screening and optimization validated with crystallization of membrane proteins , 2006, Proceedings of the National Academy of Sciences.
[30] J. Ballesteros,et al. Improvements in G protein-coupled receptor purification yield light stable rhodopsin crystals. , 2006, Journal of structural biology.
[31] Krzysztof Palczewski,et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.
[32] Kenneth Lundstrom,et al. Latest development in drug discovery on G protein-coupled receptors. , 2006, Current protein & peptide science.
[33] Robert J. Lefkowitz,et al. Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of Cyclic Nucleotide Phosphodiesterases , 2012 .
[34] T. Okada,et al. Local peptide movement in the photoreaction intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.
[35] T. Okada,et al. Crystallographic analysis of primary visual photochemistry. , 2006, Angewandte Chemie.
[36] Jaroslav Koca,et al. CAVER: a new tool to explore routes from protein clefts, pockets and cavities , 2006, BMC Bioinformatics.
[37] Krzysztof Palczewski,et al. G protein-coupled receptor rhodopsin. , 2006, Annual review of biochemistry.
[38] R. Horuk,et al. I want a new drug: G-protein-coupled receptors in drug development. , 2006, Drug discovery today.
[39] Prashant V Desai,et al. Homology modeling of G-protein-coupled receptors and implications in drug design. , 2006, Current medicinal chemistry.
[40] Stephen R Quake,et al. A microfluidic device for kinetic optimization of protein crystallization and in situ structure determination. , 2006, Journal of the American Chemical Society.
[41] G. Schertler. Structure of rhodopsin and the metarhodopsin I photointermediate. , 2005, Current opinion in structural biology.
[42] O. Civelli,et al. GPCR deorphanizations: the novel, the known and the unexpected transmitters. , 2005, Trends in pharmacological sciences.
[43] Krzysztof Palczewski,et al. Oligomerization of G protein-coupled receptors: past, present, and future. , 2004, Biochemistry.
[44] A. Engel,et al. Rhodopsin Signaling and Organization in Heterozygote Rhodopsin Knockout Mice* , 2004, Journal of Biological Chemistry.
[45] T. Mielke,et al. Electron crystallography reveals the structure of metarhodopsin I , 2004, The EMBO journal.
[46] Marcus Elstner,et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.
[47] Graeme Milligan,et al. G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.
[48] Krzysztof Palczewski,et al. A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface , 2004, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.
[49] M. Bouvier,et al. Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.
[50] Manfred Burghammer,et al. Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.
[51] S. Horio,et al. Down-Regulation: Another Possible Advantage of 2 Agonists in Asthmatic Therapy , 2004 .
[52] S. Horio,et al. Beta(2)-adrenergic receptor-mediated histamine H(1) receptor down-regulation: another possible advantage of beta(2) agonists in asthmatic therapy. , 2004, Journal of pharmacological sciences.
[53] Bryan L Roth,et al. G-protein-coupled receptors at a glance , 2003, Journal of Cell Science.
[54] K. Palczewski,et al. G protein-coupled receptor rhodopsin: a prospectus. , 2003, Annual review of physiology.
[55] Krzysztof Palczewski,et al. The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors. , 2003, Annual review of biophysics and biomolecular structure.
[56] Jamel S. Sandidge. Arachnology: Scavenging by brown recluse spiders , 2003, Nature.
[57] K. Palczewski,et al. Ligand Channeling within a G-protein-coupled Receptor , 2003, Journal of Biological Chemistry.
[58] Krzysztof Palczewski,et al. Organization of the G Protein-coupled Receptors Rhodopsin and Opsin in Native Membranes* , 2003, Journal of Biological Chemistry.
[59] Yael Marantz,et al. Modeling the 3D structure of GPCRs: advances and application to drug discovery. , 2003, Current opinion in drug discovery & development.
[60] P. Loll. Membrane protein structural biology: the high throughput challenge. , 2003, Journal of structural biology.
[61] Krzysztof Palczewski,et al. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. , 2003, Biochemistry.
[62] A. Engel,et al. Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.
[63] H. Saibil,et al. Biophysics: is rhodopsin dimeric in native retinal rods? , 2003, Nature.
[64] H Gobind Khorana,et al. Rhodopsin structure, dynamics, and activation: a perspective from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide cross-linking. , 2003, Advances in protein chemistry.
[65] Gerhard Hessler,et al. Drug Design Strategies for Targeting G-Protein-Coupled Receptors , 2002 .
[66] S. Quake,et al. A robust and scalable microfluidic metering method that allows protein crystal growth by free interface diffusion , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[67] Gerhard Hessler,et al. Drug Design Strategies for Targeting G‐Protein‐Coupled Receptors , 2002, Chembiochem : a European journal of chemical biology.
[68] A. Hopkins,et al. The druggable genome , 2002, Nature Reviews Drug Discovery.
[69] J. Saldanha,et al. Seven-transmembrane receptors: crystals clarify. , 2002, Trends in pharmacological sciences.
[70] Alan Wise,et al. Target validation of G-protein coupled receptors. , 2002, Drug discovery today.
[71] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[72] D C Teller,et al. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.
[73] K. Palczewski,et al. Activation of rhodopsin: new insights from structural and biochemical studies. , 2001, Trends in biochemical sciences.
[74] T. Sakmar,et al. Rhodopsin: structural basis of molecular physiology. , 2001, Physiological reviews.
[75] International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome , 2001, Nature.
[76] K. Palczewski,et al. X-Ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. , 2000, Journal of structural biology.
[77] J. Drews. Drug discovery: a historical perspective. , 2000, Science.
[78] U. Gether. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.
[79] A. Terakita,et al. Selective activation of G‐protein subtypes by vertebrate and invertebrate rhodopsins , 1998, FEBS letters.
[80] T. Kouyama,et al. Highly Selective Separation of Rhodopsin from Bovine Rod Outer Segment Membranes Using Combination of Divalent Cation and Alkyl(thio)glucoside , 1998, Photochemistry and photobiology.
[81] K. Palczewski,et al. Mechanisms of Opsin Activation* , 1996, The Journal of Biological Chemistry.
[82] D. Oprian,et al. A general method for mapping tertiary contacts between amino acid residues in membrane-embedded proteins. , 1995, Biochemistry.
[83] E. Ross,et al. Chimeric muscarinic cholinergic:beta-adrenergic receptors that are functionally promiscuous among G proteins. , 1994, The Journal of biological chemistry.
[84] D. Mccormick. Sequence the Human Genome , 1986, Bio/Technology.